“…Dkk-3 is downregulated in various type of cancer, including non-small-cell lung carcinoma (Tsuji et al, 2000;Nozaki et al, 2001), acute lymphoblastic leukemia (Roman-Gomez et al, 2004a) hepatocellular carcinoma (Hsieh et al, 2004), and renal cell carcinoma (Kurose et al, 2004). Although the Dkk-3 gene is localized on chromosome 11p15 where loss of heterozygocity in human cancers is often observed (Tsuji et al, 2000), several lines of evidence have shown that Dkk-3 downregulation in cancers is owing to promoter hypermethylation (Kobayashi et al, 2002;Lodygin et al, 2005).…”